{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T21:40:15Z","timestamp":1790199615431,"version":"4.1.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2007,10,1]],"date-time":"2007-10-01T00:00:00Z","timestamp":1191196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,10,1]],"date-time":"2007-10-01T00:00:00Z","timestamp":1191196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,12]],"date-time":"2023-08-12T00:00:00Z","timestamp":1691798400000},"content-version":"vor","delay-in-days":5794,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2007,10]]},"DOI":"10.1016\/j.nurt.2007.07.008","type":"journal-article","created":{"date-parts":[[2007,10,23]],"date-time":"2007-10-23T06:23:53Z","timestamp":1193120633000},"page":"618-626","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"title":["Corticosteroids for Multiple Sclerosis: I. Application for Treating Exacerbations"],"prefix":"10.1016","volume":"4","author":[{"given":"Elliot M.","family":"Frohman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjali","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Eggenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luanne","family":"Metz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Zivadinov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olaf","family":"St\u00fcve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nurt.2007.07.008_bib1","first-page":"55","article-title":"Untersuchungen \u00fcber die bei der multiplen Herdsklerose vorkommenden Augenstorungen","volume":"20","author":"Uhthoff","year":"1889","journal-title":"Arch Psychiatr Nervenkrankh"},{"key":"10.1016\/j.nurt.2007.07.008_bib2","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jneuroim.2005.11.006","article-title":"Multiple toll-like receptor agonists act as potent adjuvants in the induction of autoimmunity","volume":"172","author":"Hansen","year":"2006","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.nurt.2007.07.008_bib3","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1212\/WNL.58.2.169","article-title":"Disease modifying therapies in multiple sclerosis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines","volume":"58","author":"Goodin","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.nurt.2007.07.008_bib4","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1097\/00002281-199411000-00008","article-title":"Current treatment of the inflammatory myopathies","volume":"6","author":"Dalakas","year":"1994","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.nurt.2007.07.008_bib5","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1056\/NEJM199507203330302","article-title":"The effect of glucocorticoids on joint destruction in rheumatoid arthritis","volume":"333","author":"Kirwan","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nurt.2007.07.008_bib6","first-page":"25","article-title":"Immunosuppressive therapy for vasculitis","volume":"7","author":"Hall","year":"1995","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.nurt.2007.07.008_bib7","first-page":"20","article-title":"Distinguishing polyarteritis nodosa from microscopic polyangiitis and implications for treatment","volume":"7","author":"Guillevin","year":"1995","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.nurt.2007.07.008_bib8","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1002\/art.1780400807","article-title":"Effects of pulse methylprednisolone on inflammatory mediators in peripheral blood, synovial fluid, and synovial membrane in rheumatoid arthritis","volume":"40","author":"Youssef","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.nurt.2007.07.008_bib9","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1212\/WNL.50.1.224","article-title":"Effects of intravenous methylprednisolone therapy on leukocyte and soluble adhesion molecule expression in MS","volume":"50","author":"Droogan","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.nurt.2007.07.008_bib10","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0022-510X(97)00159-7","article-title":"The effects of high-dose intravenous methylprednisolone on event-related potentials in patients with multiple sclerosis","volume":"152","author":"Filipovic","year":"1997","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.nurt.2007.07.008_bib11","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1034\/j.1600-0404.2002.1o135.x","article-title":"Changes of the MS Functional Composite and EDSS during and after treatment of relapses with methylprednisolone in patients with multiple sclerosis","volume":"105","author":"Patzold","year":"2002","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.nurt.2007.07.008_bib12","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1136\/jnnp.2005.065284","article-title":"Quantification of central motor conduction deficits in multiple sclerosis patients before and after treatment of acute exacerbation by methylprednisolone","volume":"77","author":"Humm","year":"2006","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.nurt.2007.07.008_bib13","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1002\/1529-0131(199805)41:5<761::AID-ART2>3.0.CO;2-M","article-title":"A new hypothesis of modular glucocorticoid actions: steroid treatment of rheumatic diseases revisited","volume":"41","author":"Buttgereit","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.nurt.2007.07.008_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-5728(01)00330-7","article-title":"Mechanism of action of glucocorticosteroid hormones: possible implications for therapy of neuroimmunological disorders","volume":"117","author":"Gold","year":"2001","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.nurt.2007.07.008_bib15","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1146\/annurev.physiol.59.1.365","article-title":"Specific, nongenomic actions of steroid hormones","volume":"59","author":"Wehling","year":"1997","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.nurt.2007.07.008_bib16","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.7326\/0003-4819-119-12-199312150-00007","article-title":"Glucocorticoid therapy for immune-mediated diseases: basic and clinical correlates","volume":"119","author":"Boumpas","year":"1993","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.nurt.2007.07.008_bib17","doi-asserted-by":"crossref","first-page":"649","DOI":"10.2174\/138945006777435344","article-title":"New insights into the molecular mechanisms of corticosteroids actions","volume":"7","author":"Adcock","year":"2006","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.nurt.2007.07.008_bib18","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1210\/jcem.85.5.6516","article-title":"Mannheim classification of nongenomically initiated (rapid) steroid action(s)","volume":"85","author":"Falkenstein","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.nurt.2007.07.008_bib19","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0006-2952(99)00090-8","article-title":"Equivalent doses and relative drug potencies for non-genomic glucocorticoid effects: a novel glucocorticoid hierarchy","volume":"58","author":"Buttgereit","year":"1999","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.nurt.2007.07.008_bib20","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/35081571","article-title":"Metalloproteinases in biology and pathology of the nervous system","volume":"2","author":"Yong","year":"2001","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.nurt.2007.07.008_bib21","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1212\/WNL.46.6.1626","article-title":"Effect of steroids on CSF matrix metalloproteinases in multiple sclerosis: relation to blood-brain barrier injury","volume":"46","author":"Rosenberg","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.nurt.2007.07.008_bib22","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1126\/science.2063198","article-title":"A corticosteroid receptor in neuronal membranes","volume":"252","author":"Orchinik","year":"1991","journal-title":"Science"},{"key":"10.1016\/j.nurt.2007.07.008_bib23","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1126\/science.3563523","article-title":"Glucocorticoid receptor-like antigen in lymphoma cell membranes: correlation to cell lysis","volume":"236","author":"Gametchu","year":"1987","journal-title":"Science"},{"key":"10.1016\/j.nurt.2007.07.008_bib24","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1096\/fasebj.7.13.8405814","article-title":"Use of receptor antibodies to demonstrate membrane glucocorticoid receptor in cells from human leukemic patients","volume":"7","author":"Gametchu","year":"1993","journal-title":"FASEB J"},{"key":"10.1016\/j.nurt.2007.07.008_bib25","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/1097-4644(20010401)81:1<149::AID-JCB1031>3.0.CO;2-W","article-title":"5\u2032UTR sequences of the glucocorticoid receptor 1A transcript encode a peptide associated with translational regulation of the glucocorticoid receptor","volume":"81","author":"Diba","year":"2001","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.nurt.2007.07.008_bib26","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1385\/IR:35:3:249","article-title":"Following the TRAIL to apoptosis","volume":"35","author":"Chaudhari","year":"2006","journal-title":"Immunol Res"},{"key":"10.1016\/j.nurt.2007.07.008_bib27","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1385\/IR:36:1:3","article-title":"Apoptosis and autoimmunity","volume":"36","author":"Navratil","year":"2006","journal-title":"Immunol Res"},{"key":"10.1016\/j.nurt.2007.07.008_bib28","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1042\/bj3260329","article-title":"Methylprednisolone inhibits uptake of Ca2+ and Na+ ions into concanavalin A-stimulated thymocytes","volume":"326","author":"Buttgereit","year":"1997","journal-title":"Biochem J"},{"key":"10.1016\/j.nurt.2007.07.008_bib29","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1093\/brain\/123.7.1431","article-title":"T-cell apoptosis in situ in experimental autoimmune encephalomyelitis following methylprednisolone pulse therapy","volume":"123","author":"Schmidt","year":"2000","journal-title":"Brain"},{"key":"10.1016\/j.nurt.2007.07.008_bib30","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1146\/annurev.iy.08.040190.003051","article-title":"The T lymphocyte in experimental allergic encephalomyelitis","volume":"8","author":"Zamvil","year":"1990","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.nurt.2007.07.008_bib31","doi-asserted-by":"crossref","first-page":"383","DOI":"10.3181\/00379727-111-27799","article-title":"Enhancement of experimental allergic encephalomyelitis by adrenalectomy","volume":"111","author":"Levine","year":"1962","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1016\/j.nurt.2007.07.008_bib32","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0165-5728(96)00043-4","volume":"70","author":"McCombe","year":"1996","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.nurt.2007.07.008_bib33","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0022-510X(91)90219-W","article-title":"Apoptosis in the nervous system in experimental allergic encephalomyelitis","volume":"104","author":"Pender","year":"1991","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.nurt.2007.07.008_bib34","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1212\/WNL.36.2.238","article-title":"High-dose intravenous methylprednisolone in the treatment of multiple sclerosis: clinical-immunologic correlations","volume":"36","author":"Durelli","year":"1986","journal-title":"Neurology"},{"key":"10.1016\/j.nurt.2007.07.008_bib35","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1056\/NEJM199202273260901","article-title":"A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis","volume":"326","author":"Beck","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nurt.2007.07.008_bib36","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1212\/WNL.51.2.529","article-title":"Double-blind, randomized, placebo-controlled study of oral, high-dose methylprednisolone in attacks of MS","volume":"51","author":"Sellebjerg","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.nurt.2007.07.008_bib37","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s004150070172","article-title":"Steroids for multiple sclerosis and optic neuritis: a meta-analysis of randomized controlled clinical trials","volume":"247","author":"Brusaferri","year":"2000","journal-title":"J Neurol"},{"key":"10.1016\/j.nurt.2007.07.008_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1212\/WNL.20.5_Part_2.1","article-title":"Cooperative study in the evaluation of therapy in multiple sclerosis: ACTH vs. placebo\u2014final report","volume":"20","author":"Rose","year":"1970","journal-title":"Neurology"},{"key":"10.1016\/j.nurt.2007.07.008_bib39","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1136\/jnnp.2005.065284","article-title":"Quantification of central motor conduction deficits in multiple sclerosis patients before and after treatment of acute exacerbation by methylprednisolone","volume":"77","author":"Humm","year":"2006","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.nurt.2007.07.008_bib40","unstructured":"Filippini G, Brusaferri F, Sibley WA, Citterio A, Ciucci G, Midgard R, Candelise L. Corticosteroids or ACTH for acute exacerbations in multiple sclerosis."},{"issue":"4","key":"10.1016\/j.nurt.2007.07.008_bib41","article-title":"Corticosteroids or ACTH for acute exacerbations in multiple sclerosis","author":"Ciucci","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.nurt.2007.07.008_bib42","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1191\/1352458502ms838oa","article-title":"Cerebral volume changes in multiple sclerosis patients treated with high-dose intravenous methylprednisolone","volume":"8","author":"Hoogervorst","year":"2002","journal-title":"Mult Scler"},{"key":"10.1016\/j.nurt.2007.07.008_bib43","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/j.1600-0404.1989.tb03928.x","article-title":"A possible harmful late effect of methylprednisolone therapy on a time cluster of optic neuritis","volume":"80","author":"Herishanu","year":"1989","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.nurt.2007.07.008_bib44","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/ana.20858","article-title":"Immune surveillance in multiple sclerosis patients treated with natalizumab","volume":"59","author":"St\u00fcve","year":"2006","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nurt.2007.07.008_bib45","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1001\/archneur.63.10.1383","article-title":"Altered CD4:CD8 T cells ratios in cerebrospinal fluid of natalizumab-treated multiple sclerosis patients","volume":"63","author":"St\u00fcve","year":"2006","journal-title":"Arch Neurol"},{"key":"10.1016\/j.nurt.2007.07.008_bib46","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1001\/archneur.64.2.169","article-title":"The potential risk of progressive multifocal leukoencephalopathy with natalizumab therapy: possible interventions","volume":"64","author":"St\u00fcve","year":"2007","journal-title":"Arch Neurol"},{"key":"10.1016\/j.nurt.2007.07.008_bib47","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1212\/WNL.52.7.1479","article-title":"A randomized, controlled trial of oral high-dose methylprednisolone in acute optic neuritis","volume":"52","author":"Sellebjerg","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.nurt.2007.07.008_bib48","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1136\/jnnp.56.11.1219","article-title":"Methylprednisolone in multiple sclerosis: a comparison of oral with intravenous therapy at equivalent high dose","volume":"56","author":"Alam","year":"1993","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.nurt.2007.07.008_bib49","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/S0140-6736(96)06453-7","article-title":"Randomised trial of oral and intravenous methylprednisolone in acute relapses of multiple sclerosis","volume":"349","author":"Barnes","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.nurt.2007.07.008_bib50","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1212\/WNL.53.9.2093","article-title":"Gastric tolerance of high-dose pulse oral prednisone in multiple sclerosis","volume":"53","author":"Metz","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.nurt.2007.07.008_bib51","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1212\/01.WNL.0000138572.82125.F5","article-title":"The bioavailability of IV methylprednisolone and oral prednisone in multiple sclerosis","volume":"63","author":"Morrow","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.nurt.2007.07.008_bib52","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/j.1875-9114.1991.tb04300.x","article-title":"Interaction of dexamethasone with phenytoin","volume":"11","author":"Lackner","year":"1991","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.nurt.2007.07.008_bib53","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1002\/bdra.10134","article-title":"First trimester exposure to corticosteroids and oral clefts","volume":"67","author":"Pradat","year":"2003","journal-title":"Birth Defects Res A Clin Mol Terato"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923006165?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923006165?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1016\/j.nurt.2007.07.008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T06:39:29Z","timestamp":1761806369000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747923006165"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10]]},"references-count":53,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,10]]}},"alternative-id":["S1878747923006165"],"URL":"https:\/\/doi.org\/10.1016\/j.nurt.2007.07.008","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2007,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Corticosteroids for Multiple Sclerosis: I. Application for Treating Exacerbations","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nurt.2007.07.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 The American Society for Experimental NeuroTherapeutics, Inc. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}